Bicalutamide Alternatives Compared
| Bicalutamide | Casodex | Zytiga |
|
|---|
| Bicalutamide | Casodex bicalutamide | Zytiga abiraterone |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescribed for Prostate Cancer. bicalutamide may also be used for purposes not listed in this medication guide. |
Casodex is an androgen receptor inhibitor that may be used in combination with an LHRH agonist (such as leuprolide or goserelin) for the treatment of prostate cancer. Hot flashes are the main side... View more |
Prescribed for Prostate Cancer. Zytiga may also be used for purposes not listed in this medication guide. |
Choose a suggestion below Prostate Cancer
Popular Comparisons
|
|||||||||||||||||||||||
| More about Bicalutamide | More about Casodex (bicalutamide) | More about Zytiga (abiraterone) | ||||||||||||||||||||||||
| Generic Status | ||||||||||||||||||||||||||
| Availability | ||||||||||||||||||||||||||
|
Prescription only |
Prescription only |
Prescription only |
||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Bicalutamide has an average rating of 8.0 out of 10 from a total of 10 ratings on Drugs.com. 78% of reviewers reported a positive effect, while 11% reported a negative effect. |
Casodex has an average rating of 7.8 out of 10 from a total of 7 ratings on Drugs.com. 83% of reviewers reported a positive effect, while 17% reported a negative effect. |
Zytiga has an average rating of 8.8 out of 10 from a total of 36 ratings on Drugs.com. 87% of reviewers reported a positive effect, while 7% reported a negative effect. |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Side Effects | ||||||||||||||||||||||||||
|
Commonly reported side effects include: abdominal pain, nausea, mastalgia. See the full bicalutamide side effects document. |
Common side effects include: abdominal pain, nausea, mastalgia. See the full Casodex side effects document. |
Common side effects include: decreased serum potassium, increased serum aspartate aminotransferase, increased serum triglycerides, fluid retention, hypokalemia. See the full Zytiga side effects document. |
||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all bicalutamide prices |
View all Casodex prices and generic prices |
View all Zytiga prices and generic prices |
||||||||||||||||||||||||
| Dosage Form(s) Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Casodex |
N/A |
Other abiraterone brands include: Yonsa | ||||||||||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
|
240 hours |
240 hours |
19 hours |
||||||||||||||||||||||||
| CSA Schedule** View glossary of terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category X
Not for use in pregnancy
See the full Pregnancy Warnings document. |
Category X
Not for use in pregnancy
See the full Pregnancy Warnings document. |
Category X
Not for use in pregnancy
See the full Pregnancy Warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 343 drugs are known to interact with bicalutamide:
|
A total of 343 drugs are known to interact with Casodex:
|
A total of 394 drugs are known to interact with Zytiga:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
October 04, 1995 |
October 04, 1995 |
April 28, 2011 |
||||||||||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.